Clinical Trial Update: Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial explores neoadjuvant chemoimmunotherapy for stage IIIA (N2) and IIIB non-small cell lung cancer and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: West China Hospital | Conditions: Non-small Cell Lung Cancer Stage ⅢA, Non-small Cell Lung Cancer Stage IIIB | Status: NOT_YET_RECRUITING